Dr. Hu research program mainly focuses on DNA repair pathways and immune/inflammatory responses in breast cancer risk, treatment responses, adverse responses, and survival disparities. Her current research has been devoted to translating cancer genomics to targeted intervention using multiple OMICs approaches to characterize metabolomics reprogramming and dysregulated cancer genomic pathways in breast cancer.